Dashboard
Manage Tickers

ELV


()    

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

cantor-fitzgerald-reiterates-overweight-on-elevance-health-maintains-600-price-target
Cantor Fitzgerald Reiterates Overweight on...
09/10/2024 15:29:16

Cantor Fitzgerald analyst Sarah James reiterates Elevance Health (NYSE:ELV) with a Overweight and maintains $600 price target.

100-invested-in-elevance-health-15-years-ago-would-be-worth-this-much-today
$100 Invested In Elevance Health 15 Years ...
09/06/2024 20:30:24

looking-into-elevance-healths-recent-short-interest
Looking Into Elevance Health's Recent Shor...
09/06/2024 13:15:14

13-analysts-have-this-to-say-about-elevance-health
13 Analysts Have This To Say About Elevanc...
09/05/2024 19:00:48

stephens--co-reiterates-overweight-on-elevance-health-maintains-615-price-target
Stephens & Co. Reiterates Overweight on El...
09/05/2024 17:08:01

Stephens & Co. analyst Scott Fidel reiterates Elevance Health (NYSE:ELV) with a Overweight and maintains $615 price target.

evolent-health-explores-sale-garners-inbound-interest-from-private-equity-firms
Evolent Health Explores Sale, Garners Inbo...
08/23/2024 14:32:15

Evolent Health is exploring a potential sale, drawing interest from private equity firms like TPG and KKR.

heres-how-much-1000-invested-in-elevance-health-10-years-ago-would-be-worth-today
Here's How Much $1000 Invested In Elevance...
08/22/2024 20:31:05

Core News & Articles
Evolent Health Explores Sale Following Acq...
08/22/2024 17:18:19

- Reuters Citing Sources

looking-at-elevance-healths-recent-unusual-options-activity
Looking At Elevance Health's Recent Unusua...
08/20/2024 19:16:20

10-health-care-stocks-whale-activity-in-todays-session
10 Health Care Stocks Whale Activity In To...
08/19/2024 17:35:23

what-analysts-are-saying-about-elevance-health-stock
What Analysts Are Saying About Elevance He...
08/19/2024 16:00:40

cantor-fitzgerald-reiterates-overweight-on-elevance-health-maintains-600-price-target
Cantor Fitzgerald Reiterates Overweight on...
08/19/2024 15:26:32

Cantor Fitzgerald analyst Sarah James reiterates Elevance Health (NYSE:ELV) with a Overweight and maintains $600 price target.

an-irrelevant-company-jim-cramer-says-snap-is-not-investable
'An Irrelevant Company': Jim Cramer Says S...
08/13/2024 12:50:01

Jim Cramer suggests buying Applied Materials despite government concerns, Aflac not favored, UnitedHealth Group best, Snap not ...

10-health-care-stocks-with-whale-alerts-in-todays-session
10 Health Care Stocks With Whale Alerts In...
08/12/2024 17:35:22

1000-invested-in-this-stock-20-years-ago-would-be-worth-13000-today
$1000 Invested In This Stock 20 Years Ago ...
08/07/2024 20:30:18

if-you-invested-1000-in-this-stock-15-years-ago-you-would-have-10000-today
If You Invested $1000 In This Stock 15 Yea...
07/25/2024 18:00:21

how-is-the-market-feeling-about-elevance-health
How Is The Market Feeling About Elevance H...
07/23/2024 18:00:20

cantor-fitzgerald-reiterates-overweight-on-elevance-health-maintains-600-price-target
Cantor Fitzgerald Reiterates Overweight on...
07/23/2024 16:07:24

Cantor Fitzgerald analyst Sarah James reiterates Elevance Health (NYSE:ELV) with a Overweight and maintains $600 price target.

wells-fargo-maintains-overweight-on-elevance-health-lowers-price-target-to-593
Wells Fargo Maintains Overweight on Elevan...
07/22/2024 13:48:58

Wells Fargo analyst Stephen Baxter maintains Elevance Health (NYSE:ELV) with a Overweight and lowers the price target from $...

td-cowen-maintains-buy-on-elevance-health-lowers-price-target-to-589
TD Cowen Maintains Buy on Elevance Health,...
07/19/2024 16:42:03

TD Cowen analyst Ryan Langston maintains Elevance Health (NYSE:ELV) with a Buy and lowers the price target from $624 to $589.

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION